Finasteride

Chemical formula: C₂₃H₃₆N₂O₂  Molecular mass: 372.544 g/mol  PubChem compound: 57363

Therapeutic indications

Finasteride is indicated for:

Benign prostatic hyperplasia (BPH)

Population group: men, only adults (18 years old or older)

Finasteride is indicated for the treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate to:

  • cause regression of the enlarged prostate, improve urinary flow and improve the symptoms associated with BPH
  • reduce the incidence of acute urinary retention and the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Finasteride is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: PROSCAR Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈